Organon Revenue 2019-2023 | OGN
Organon revenue from 2019 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Organon Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $6,263 |
| 2022 | $6,174 |
| 2021 | $6,304 |
| 2020 | $6,532 |
| 2019 | $7,777 |
| 2018 | $9,777 |
| Organon Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | $1,598 |
| 2023-09-30 | $1,519 |
| 2023-06-30 | $1,608 |
| 2023-03-31 | $1,538 |
| 2022-12-31 | $1,485 |
| 2022-09-30 | $1,537 |
| 2022-06-30 | $1,585 |
| 2022-03-31 | $1,567 |
| 2021-12-31 | $1,603 |
| 2021-09-30 | $1,600 |
| 2021-06-30 | $1,595 |
| 2021-03-31 | $1,506 |
| 2020-12-31 | $1,613 |
| 2020-09-30 | $1,613 |
| 2020-06-30 | $1,526 |
| 2020-03-31 | $1,780 |
| 2019-12-31 | |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $4.709B | $6.263B |
| Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.431B | 15.74 |
| Cencora (COR) | United States | $47.828B | 19.09 |
| ICON (ICLR) | Ireland | $24.755B | 23.37 |
| DiDi Global (DIDIY) | China | $23.950B | 0.00 |
| Avantor (AVTR) | United States | $17.059B | 23.50 |
| Viatris (VTRS) | United States | $13.760B | 3.93 |
| CochLear (CHEOY) | $13.446B | 0.00 | |
| Revvity (RVTY) | United States | $12.611B | 21.95 |
| Medpace Holdings (MEDP) | United States | $12.076B | 39.73 |
| Charles River Laboratories (CRL) | United States | $11.735B | 21.39 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.550B | 0.00 |
| Natera (NTRA) | United States | $11.158B | 0.00 |
| Solventum (SOLV) | United States | $10.666B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.782B | 50.67 |
| Bausch + Lomb (BLCO) | Canada | $5.187B | 19.95 |
| Doximity (DOCS) | United States | $4.401B | 32.76 |
| PACS (PACS) | United States | $3.643B | 0.00 |
| Sotera Health (SHC) | United States | $3.204B | 15.72 |
| Surgery Partners (SGRY) | United States | $3.145B | 29.22 |
| Progyny (PGNY) | United States | $3.124B | 52.42 |
| GoodRx Holdings (GDRX) | United States | $2.797B | 141.60 |
| Life Times (LTH) | United States | $2.776B | 30.67 |
| Premier (PINC) | United States | $2.493B | 9.13 |
| Teladoc Health (TDOC) | United States | $2.257B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.131B | 6.89 |
| Agilon Health (AGL) | United States | $2.109B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.782B | 0.00 |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| Establishment Labs Holdings (ESTA) | $1.333B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.316B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.975B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.748B | 7.74 |
| Embecta (EMBC) | United States | $0.599B | 3.95 |
| Auna S.A (AUNA) | Luxembourg | $0.531B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.516B | 0.00 |
| Enhabit (EHAB) | United States | $0.495B | 44.86 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.487B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.438B | 0.00 |
| LifeMD (LFMD) | United States | $0.437B | 0.00 |
| CareDx (CDNA) | United States | $0.391B | 0.00 |
| Beauty Health (SKIN) | United States | $0.378B | 0.00 |
| MultiPlan (MPLN) | United States | $0.368B | 0.00 |
| DocGo (DCGO) | United States | $0.364B | 58.17 |
| ModivCare (MODV) | United States | $0.340B | 4.51 |
| Sera Prognostics (SERA) | United States | $0.335B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.291B | 0.00 |
| Sharecare (SHCR) | United States | $0.266B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.256B | 0.00 |
| Biodesix (BDSX) | United States | $0.145B | 0.00 |
| So-Young (SY) | China | $0.123B | 41.33 |
| Oncology Institute (TOI) | United States | $0.088B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.076B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.032B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.027B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| OncoCyte (OCX) | United States | $0.020B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.015B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| Assure Holdings (IONM) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |